Sanofi Consumer Healthcare Reaches 'Next Level Of Autonomy'
The integration of core business functions at Sanofi Consumer Healthcare represents the “next level of autonomy” for the business, according to group CFO Jean-Baptiste Chasseloup de Chatillon. “As a result, you can expect a much enhanced CHC disclosure, allowing you easy peer comparisons and our team benchmark will be easier and more compelling.” The move came as Sanofi Consumer Healthcare reported a strong end to 2022, with Q4 sales up by 6.6% at constant exchange rates to €1.22bn.
You may also be interested in...
France In 2022: Pharmacy And Prevention Trends Drive Double-Digit OTC Growth
Consumers visiting pharmacies for preventative health products like food supplements drove strong growth in France's consumer healthcare market in 2022. To build on this success, the country's OTC manufacturers' association, NèreS, is calling for a national self-care strategy that would promote pharmacists as the go-to healthcare professionals for self-care.
Surprise, Skepticism And Scorn: Reaction To Rumored Haleon Interest In Sanofi CHC
Analysts share their thoughts on reports that Haleon is interested in acquiring Sanofi Consumer Healthcare to enhance its market leading position.
Zentiva Grows In Italy With Acquisition Of Sanofi OTC Brands
Zentiva adds the Zerinol and Schoum Solution OTC brands to its Italian portfolio as Sanofi continues to offload non-core consumer health brands to focus on its priority categories.